Centene (NYSE:CNC – Get Free Report) released its earnings results on Friday. The company reported $2.42 EPS for the quarter, topping analysts’ consensus estimates of $1.80 by $0.62, RTT News reports. The company had revenue of $39.84 billion for the quarter, compared to analysts’ expectations of $36.83 billion. Centene had a return on equity of 14.19% and a net margin of 1.76%. The business’s revenue for the quarter was up 5.9% compared to the same quarter last year. During the same period in the previous year, the business posted $2.10 EPS.
Centene Price Performance
Shares of NYSE CNC traded up $5.70 during midday trading on Friday, hitting $73.10. 9,637,301 shares of the company’s stock were exchanged, compared to its average volume of 3,466,414. Centene has a 12-month low of $60.83 and a 12-month high of $81.42. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.66. The company has a market cap of $39.01 billion, a price-to-earnings ratio of 14.22, a PEG ratio of 0.89 and a beta of 0.50. The business’s fifty day moving average price is $69.13 and its two-hundred day moving average price is $73.79.
Insider Transactions at Centene
In other Centene news, Director Christopher J. Coughlin sold 878 shares of the company’s stock in a transaction that occurred on Tuesday, May 14th. The stock was sold at an average price of $76.75, for a total value of $67,386.50. Following the completion of the sale, the director now owns 25,504 shares of the company’s stock, valued at $1,957,432. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Centene news, President Kenneth J. Fasola sold 8,000 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $77.62, for a total value of $620,960.00. Following the completion of the sale, the president now owns 300,357 shares in the company, valued at $23,313,710.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Christopher J. Coughlin sold 878 shares of the business’s stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $76.75, for a total value of $67,386.50. Following the completion of the sale, the director now owns 25,504 shares of the company’s stock, valued at approximately $1,957,432. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Get Our Latest Research Report on CNC
About Centene
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Read More
- Five stocks we like better than Centene
- How to Start Investing in Real Estate
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- When to Sell a Stock for Profit or Loss
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- What is a buyback in stocks? A comprehensive guide for investors
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.